Cognition and Neurodevelopmental Disorders Workstream

Screen Shot 2015-09-24 at 15.51.01Cognition Lead
Professor Barbara J Sahakian specialises in Clinical Neuropsychology at the University of Cambridge Department of Psychiatry and MRC / Wellcom Trust Behavioural and Clinical Neuroscience Institute. She is also an Honorary Clinical Psychologist at Addenbrooke’s Hospital, Cambridge, UK. She is President of the British Association for Psychopharmacology. She is a Founder Member and on the Executive Board of the International Neuroethics Society (INS). She has recently become President of the INS. She is a Fellow of the Academy of Medical Sciences. She is co-author of ‘Bad Moves. How decision making goes wrong and the ethics of smart drugs.’ (Oxford University Press, 2013) and co-editor of The Oxford Handbook of Neuroethics (Oxford University Press, 2011).

Professor Sahakian has an international reputation in the fields of psychopharmacology, neuropsychology and neuropsychiatry and it is the research at the interaction of these for which she has made outstanding and novel contributions. Professor Sahakian has over 350 publications in high impact scientific journals, covering topics in psychopharmacology, neuropsychology, neuropsychiatry, neuroimaging and neuroethics. The ISI Web of Science database credits her with a Hirsch (h) index of 94, with some of her publications having over 300 citations.

Screen Shot 2015-09-24 at 15.51.08

Neurodevelopmental Disorders Lead
Professor Howard Ring is a clinical academic consultant psychiatrist working in the University of Cambridge and the Cambridgeshire and Peterborough Foundation Trust. He has more than 20 years’ experience in clinical work and research in neuropsychiatry, originally training at the Maudsley Hospital and the Institute of Neurology, Queen Square, both in London.

Professor Ring’s interests relate to research, education and clinical service development in neuropsychiatry and the psychiatry of developmental intellectual disabilities (ID). Current research initiatives include the study of non-pharmacological approaches to epilepsy management in adults with ID and the application of EEG and psychophysiological measures to investigate biological associations of behavioural symptoms in people with neurodevelopmental disorders. He is also the east of England training programme director for the psychiatry of intellectual disability and the programme director for clinical academic training in psychiatry at the University of Cambridge.

 Supported projects